Table 3.

Summary of results obtained from the case–case association analysis of the G84E mutation and selected clinical features

Age at diagnosisG84E carriers% (n)G84E noncarriers% (n)P valueOR (95% CI)
 ≤55 y6.25 (13)93.75 (195)0.00079592.0 (1.3–3.0)
 >55 y3.40 (148)96.60 (4,209)
PSA at diagnosis
 ≥20 ng/mL4.56 (39)95.44 (816)0.0061871.4 (1.1–1.9)
 <20 ng/mL3.19 (110)96.81 (3,336)
PSA progression
 Present3.76 (39)96.24 (997)0.50341.1 (0.8–1.4)
 Absent3.51 (124)96.49 (3,406)
Gleason score
 ≥84.04 (22)95.96 (523)0.099181.3 (1.0–1.9)
 ≤63.11 (70)96.89 (2,182)

NOTE: The statistically significant P values are italicized.